Background: Evidence shows that high Medicare spending is not associated with better health outcomes at a regional level and that high spending in hospitals is not associated with better process quality. The relationship between hospital spending and inpatient mortality is less well understood.
A
convincing set of studies demonstrates that U.S. regions that spend more on medical care have similar or poorer patient outcomes than areas that spend less on medical care (1, 2) . Regions vary widely in both spending and quality of care, with high-spending regions using more specialists, diagnostic tests and imaging, and inpatient hospital care, yet generally producing no better care (2) . The implication of these studies for health care reform and for curbing growth in health care spending is heavily debated (3) (4) (5) (6) .
Examining variation in total medical spending across regions provides an informative overall picture; however, medical spending may lead to better patient outcomes in some circumstances (for example, inpatient hospital spending) but not in others (7) . For example, a recent study of 6 California teaching hospitals found that patients with congestive heart failure (CHF) had lower mortality rates when treated at hospitals where lengths of stay and total costs were higher (8) . A related study of Pennsylvania acute care hospitals demonstrated that patients in hospitals with higher intensity in end-of-life treatment (for example, intensive care unit admission and mechanical ventilation) had lower rates of postadmission mortality (9) .
Building on this prior work, we analyzed the association between hospital spending-the sum of spending on inpatient physician visits, hospital room charges, laboratory testing, diagnostic imaging, medication administration, and procedures-and inpatient mortality for the periods , a period during which hospital spending information was unavailable in the Dartmouth Atlas, we computed diagnosis-specific hospital-level spending on the basis of patients who died while hospitalized. For each diagnosis in each period, we estimated patient-level logistic models of the association between hospital spending and inpatient hospital mortality. In addition to patient comorbid conditions and sociodemographic characteristics and hospital and regional factors, we used validated risk adjustment models developed by the Agency for Healthcare Research and Quality (AHRQ) to account for inpatient mortality risk.
METHODS
We analyzed hospital spending and inpatient mortality in 208 California hospitals for 1999 to 2003 and 2004 to 2008 . We selected all California hospitals that were included in the most recent version of the Dartmouth Atlas, which reported measures of hospital spending during 1999 to 2003. Whether a hospital was or was not included in the Dartmouth Atlas, and therefore was or was not included in our study, was based on the number of Medicare fee-forservice beneficiaries admitted to that hospital. Our sample of hospitals accounted for about two thirds of all California discharges over the study periods.
Study Sample
We studied 6 medical conditions: acute myocardial infarction (AMI), CHF, acute stroke, gastrointestinal hemorrhage, hip fracture, and pneumonia. These conditions were chosen because the processes of care associated with them are important inpatient quality indicators (10), the acute conditions are closely related to chronic conditions in the Dartmouth Atlas, and they comprise a substantial portion of all admissions in the hospitals studied (11% during  1999 to 2003 and 10% during 2004 to 2008) .
We identified all admissions during 1999 to 2003 and 2004 to 2008 on the basis of deidentified discharge records from the California Office of Statewide Health Planning and Development. The institutional review board at RAND Corporation determined these deidentified data to be exempt from human subjects review. In addition to a hospital identification number, each discharge record included patient age; sex; admission year and quarter; International Classification of Diseases, Ninth Revision (ICD-9), codes for principal and secondary diagnoses and procedures; disposition (for example, in-hospital death); charges; and 5-digit ZIP code of residence. Following prior research (11), we linked each discharge record to patient ZIP code-level sociodemographic data from the 2000 U.S. Census, including median annual household income; average annual Social Security income; and percentage of the population who were living below the poverty level, were employed, had less than a high school education, were Hispanic, were single, lived in an urban area, were elderly, were elderly living in institutions, and were noninstitutionalized elderly with various disabilities. We then created diagnosis-specific patient samples for each hospital from ICD-9 discharge codes, according to the criteria of the AHRQ Inpatient Quality Indicators, version 3.2 (AHRQ, Rockville, Maryland). Patients admitted with AMI included transfers from other hospitals; our results were unchanged when transfers were excluded.
Hospital Spending
For 1999 to 2003, we took the average hospital spending from the 2008 Dartmouth Atlas (12) . This edition tracked spending in the last 2 years of life among fee-forservice Medicare patients with at least 1 of 9 severe chronic illnesses. Because patients at the end of life are arguably similar in the overall severity of illness, hospital spending measures that focus on end-of-life spending are more closely related to a hospital's overall approach to spending and care rather than to the severity of its patients' illnesses (2, 12) . The Dartmouth Atlas calculates hospital spending by assigning patients to the hospital at which most inpatient care was received (12, 13) . The measure includes reimbursements to the hospital and physicians and is adjusted for age, sex, race, and primary chronic diagnosis; it is not disease-specific. In Appendix Table 1 (available at www.annals.org), we examined the relationship between inpatient mortality and a surrogate measure of end-of-life hospital care that was based on the number of days a patient spent in the hospital and the number of inpatient physician visits received during the last 2 years of life (Hospital Care Intensity Index, produced by the Dartmouth Atlas) (12) . By focusing on specific aspects of care rather than spending, this measure is not directly affected by geographic variation in prices and Medicare disproportionate share payments (12, 14, 15) .
The Dartmouth Atlas did not provide hospital spending estimates over 2004 to 2008. We therefore used hospital charges to compute disease-specific median hospital spending for patients admitted with 1 of the 6 diagnoses who died while hospitalized. Because patients could not be linked across hospital admissions, costs were from the final hospitalization rather than the total costs for these decedents in the last 2 years of life. We assumed that unmeasured severity of illness was similar among patients who died while hospitalized. We acknowledge that this is an imperfect way to adjust for mor-
Context
The relationship between health care spending and patient outcomes is complex. Studies have shown that regions with higher Medicare spending did not have better outcomes than regions with lower spending and that high spending at the hospital level is not linked to better process measures of quality. Yet, the relationship between hospital spending and inpatient mortality is poorly understood.
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Hospital Spending and Inpatient Mortality tality risk, particularly if sicker patients migrate toward intensive tertiary care hospitals. We used hospital-specific cost-tocharge ratios to convert hospital charges to costs. Hospital spending for 2004 to 2008 was therefore disease-specific, whereas spending during 1999 to 2003 was not. We converted spending during 2004 to 2008 to 2001 U.S. dollars by using the Producer Price Index for general medical and surgical hospitals.
Other Controls
We linked patient discharges to hospital-and regionlevel data, including hospital size, teaching status (11) (reported in the American Hospital Association's Annual Survey [16] ), quartile of discharge volume by condition (11) , and quartile of managed care penetration (based on hospital discharges) in the hospital referral region in the Dartmouth Atlas (1, 11) .
Statistical Analysis
For each diagnosis in each period, we estimated patient-level logistic models as follows:
Death i,h is the indicator for death of patient i in hospital h, pred_mortality i is the AHRQ patient-level predicted mortality risk, and spending h is the hospital spending in hospital h. Spending varied at the hospital level (spending h ) and was divided into quintiles (11); we considered linear and quadratic specifications in sensitivity analysis. For 1999 to 2003, hospital spending was not disease-specific, whereas it was for 2004 to 2008.
For patients admitted with each disease, we accounted for underlying health risks affecting inpatient mortality by applying risk parameters from a validated risk adjustment tool from the AHRQ (10). The AHRQ risk parameters are estimated from national discharge data and can be applied to other discharge data to predict diagnosis-specific inpatient mortality for each patient. We applied the AHRQ risk parameters to each patient in the discharge data to obtain patient-level predicted mortality risk (pred_mortali-ty i ) based on a patient's age category (such as 55 to 59 years), sex (interacted with age), and relevant diagnoses and procedure codes for the admitting diagnosis. The advantage of applying AHRQ's risk parameters (rather than directly estimating them from the California data) was that the AHRQ model estimated its risk parameters from nationally representative data. In addition to adjusting for predicted mortality, we adjusted for the number of CharlsonDeyo comorbid conditions (11, 17) , sociodemographic factors based on ZIP code of residence (11), and year of discharge. Hospital and regional factors were described (18, 19) ; this analysis also controlled for regional differences in diagnostic practices (20) . We used Stata, version 11 (StataCorp, College Station, Texas), for statistical analyses, and we calculated 95% CIs, which reflect 0.025 in each tail, or a P value of 0.05. Confidence intervals accounted for clustering of patients within hospitals. For each diagnosis and period, we predicted the number of lives saved if all patients in the sample had been admitted to hospitals in the top spending quintile versus the bottom (21) . We calculated lives saved by multiplying the total number of admissions by the absolute difference in predicted inpatient mortality based on the first and fifth quintiles of hospital spending.
We also explored whether hospital size or geography (southern California vs. rest of the state) modified the association between hospital spending and inpatient mortality. Southern California was defined as Imperial, Los Angeles, Riverside, Santa Barbara, San Bernardino, San Diego, and Ventura counties. We dichotomized hospital size into greater or less than the median number of hospital beds (220 in our sample) in 2001 financial reports. We did not examine effect modification by hospital teaching status because all but 1 teaching hospital were in the top 2 quintiles of spending.
Because this study was observational, the results could reflect unmeasured confounders. We conducted a sensitivity analysis to assess the degree of confounding needed to eliminate the estimated association between hospital spending and inpatient mortality. We assumed that the unmeasured confounder is binary and hospital-specific and is independent of measured confounders and that there is no interaction between the unmeasured confounder and spending. We used a log-linear approximation to the logistic model (22) . AMI ϭ acute myocardial infarction; CHF ϭ congestive heart failure; GI ϭ gastrointestinal. * Odds ratios of inpatient mortality for a given hospital spending quintile are calculated with respect to the lowest quintile. 69 581 patients for the preceding reasons and another 10 429 patients for whom hospital costs were unavailable (because missing or invalid charges or cost-to-charge ratios). After these exclusions, a total of 2 545 352 patients remained.
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To prevent identification, some discharge records masked patient characteristics related to sample inclusion criteria or predicted mortality. Age, sex, or admission quarter was masked for 80 307 patients during 1999 to 2003 (133 814 during 2004 to 2008). For each diagnosis and period, we created 10 independent data sets in which masked characteristics were imputed on the basis of inhospital death; Charlson-Deyo comorbidity index; hospital identification number; admission year; and where available, age, sex, and admission quarter (23). We used standard methods to combine analysis results across the imputed data sets (24) .
Role of the Funding Source
The National Institute of Aging and the RAND Health Bing Center for Health Economics sponsored our research. The funding sources had no role in the design, conduct, analysis, interpretation, and presentation of the data or in the decision to submit the manuscript for publication. Table 2 , available at www.annals .org). The number of patients was substantial, ranging from 98 208 (hip fracture) to 345 449 (pneumonia). Average age ranged from 72.5 years (AMI) to 81.4 years (hip fracture). Observed mortality ranged from 2.97% for hip fracture to 10.25% for AMI and 11.71% for stroke. About 1 of 10 patients were admitted to teaching hospitals, and about 70% were treated at hospitals with more than the median number of beds. Admissions were approximately evenly distributed between hospitals in southern California and the rest of the state. Vertical bars represent 95% CIs around the predicted lives saved. AMI ϭ acute myocardial infarction; CHF ϭ congestive heart failure; GI ϭ gastrointestinal.
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Effect of Hospital Size and Location
We also examined how hospital size and location affected the estimated relationship between hospital spending and inpatient mortality during 1999 to 2003 ( Table  4) . For each disease and subgroup comparison (for example, southern vs. rest of California), we report the OR of inpatient mortality among patients admitted to hospitals in the fifth spending quintile versus the first. The association between hospital spending and inpatient mortality did not vary statistically significantly by location or hospital size. For example, the OR of inpatient mortality for patients admitted with CHF to hospitals in the fifth quintile of spending (relative to the first quintile) was 0.854 (CI, 0.597 to 1.111) in southern California, versus 0.797 (CI, 0.645 to 0.950) in the rest of the state (P ϭ 0.71). Similar results held for the other diseases considered. The OR of inpatient CHF mortality among hospitals in the fifth quintile of spending (relative to the first) was 0.764 (CI, 0.599 to 0.928) for the larger 50% of hospitals versus 0.789 (CI, 0.640 to 0.938) for the smaller 50% (P ϭ 0.79).
Sensitivity Analysis
Results were similar when we used a surrogate measure of hospital spending, linear and quadratic specifications of hospital spending, and indicator variables for hospital regions (Appendix Tables 1, 3, and 4) . In terms of confounding, the true OR of inpatient mortality with respect to the top spend- AMI ϭ acute myocardial infarction; CHF ϭ congestive heart failure; GI ϭ gastrointestinal. * The table examines whether hospital size and location modify the association between hospital spending and inpatient mortality. Odds ratios (95% CIs) compare inpatient mortality spending between the highest and lowest quintile of hospital spending; an odds ratio Ͻ1.0 implies that adjusted inpatient mortality was lower in hospitals in the highest spending quintile than in hospitals in the lowest spending quintile.
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Hospital Spending and Inpatient Mortality www.annals.orging quintile would become statistically indistinguishable from 1.0 for patients presenting with AMI during 1999 to 2003 if there were an unmeasured binary variable with an OR of inpatient mortality of 0.85, a 20% probability of occurring at a hospital in the top spending quintile, and a 10% probability of occurring at a bottom-quintile hospital. For patients with pneumonia, the true OR would be significantly less than 1.0 even with a 100% probability of the binary variable occurring at top-spending hospitals.
DISCUSSION
We examined the association between hospital spending and inpatient mortality in 208 California hospitals. We found that greater hospital spending was associated with lower inpatient mortality for various major acute medical conditions. Our findings suggest that although greater overall medical spending in the United States is not associated with better quality of care or better health outcomes (1, 2, 11) , specific types of medical spending (for example, acute care hospital spending) may be efficacious. Our results, along with those of prior studies (8, 9) , highlight that intensive spending in hospitals may be associated with lower mortality despite having no or even a negative relationship to standard measures of process quality (for example, aspirin use at admission for patients presenting with AMI) (15, 25) . Reported process measures may simply do a poor job of explaining variation in hospital mortality (26, 27) .
Although our analysis demonstrates that intensive spending by hospitals is associated with lower mortality, it does not identify the specific costly interventions that highspending hospitals undertake to achieve this mortality benefit. Prior work suggests that patients at moderate and high risk for death have lower mortality when admitted to hospitals in which larger proportions of patients spend time in the intensive care unit, undergo mechanical ventilation, or receive dialysis (9) . These interventions are probably only proxies for the additional costly diagnostic work-up and management that higher-spending hospitals may do. For the admitting diagnoses we considered, these additional interventions may include early and more frequent coronary revascularization for AMIs and upper and lower endoscopies for gastrointestinal hemorrhages.
Our study has additional limitations. Although we measured hospital spending among patients at the end of life, adjusted for patient comorbid conditions, and accounted for patient sociodemographic characteristics by ZIP code, hard-to-measure aspects of health are still a concern (28) . Patients admitted to higher-spending hospitals may be healthier than predicted, either because of where those hospitals are located or because higher-spending hospitals have lower thresholds for hospital admission. Both of these would bias us toward finding an association between higher hospital spending and lower inpatient mortality. Whereas higher-spending hospitals may less discriminately admit patients presented with such diagnoses as CHF and pneumonia instead of managing these illnesses on an outpatient basis, acute events, such as stroke and AMI, would presumably be less affected. We find equally strong relationships between hospital spending and mortality across the range of disease acuity we consider.
An additional bias arises if higher-spending hospitals diagnose more conditions or simply attach more diagnoses to discharge records (20) . Adjustment for the number of diagnoses at discharge would bias us toward finding a negative association between hospital spending and inpatient mortality. Our results were unchanged, however, when the number of comorbid conditions was excluded from the analysis (Appendix Table 5 ). Despite the potential biases in favor of a negative association between spending and mortality, it is important to recognize that higher-spending hospitals may also spend more because their patients are sicker than our mortality risk adjustments would predict. In this case, we would understate the efficacy of hospital spending.
Our findings should be interpreted with caution. Higher hospital spending on these 6 major medical conditions may not produce better health outcomes outside of California, although we know of no reason to doubt it. Furthermore, hospital spending would not necessarily be cost-effective, because alternative interventions might enhance population health at lower cost. The cost-effectiveness of hospital spending depends on its effect on inpatient and postdischarge mortality, the latter of which we could not assess with our data. Hence, important questions about the efficacy and value of hospital care remain to be asked and answered. Odds ratios of inpatient mortality for a given hospital spending quintile are calculated with respect to the lowest quintile. Vertical bars represent 95% CIs around the predicted lives saved. AMI ϭ acute myocardial infarction; CHF ϭ congestive heart failure; GI ϭ gastrointestinal. 
